We're the world's first medical center dedicated to the research and treatment of infection-associated chronic conditions and illnesses.

Manual

Research

News

Video Resources

Open Trials

Our Patients

Scientific innovation.

Clinical excellence.

We’re on Instagram!

Adults with Long COVID in or near New York City are invited to join a six-month clinical trial for sirolimus (rapamycin)! The trial involves five in-person study visits and up to $150 in compensation, plus limited financial support for transportation
Exciting news for #NYC-area folks with chronic #babesia and severe #fatigue -- we are launching a clinical trial of tafenoquine (arakoda) at CoRE in New York City. #ChronicLyme & #MECFS patients with no current diagnosis of babesia, this is your
Exciting research news! CoRE and PolyBio continue to turn research into action with 1) new preprint findings about the efficacy of microtesla magnetic therapy (MMT) in Long COVID cognitive impairment and 2) VIPER, a massive research initiative to ide
CoRE is conducting a brief survey to better understand what people with symptoms of Infection Associated Chronic Conditions and Illnesses (IACCIs) experience when accessing medical care. Your responses will help improve healthcare services and provid
NYC-area adults with #LongCOVID - you're eligible for a clinical trial of sirolimus (rapamycin) involving 5 in-person visits over 6 months. Compensation is up to $150; if travel within NYC is a barrier to access, you can contact CoreResearch@MountSin